Ridge Preservation With Platelet Rich Fibrin Augmented With Freeze Dried Bone Allograft
NCT ID: NCT03043885
Last Updated: 2018-12-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2015-01-05
2017-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes of Soft and Hard Tissues After Alveolar Ridge Preservation: Freeze-dried Bone Allograft vs. L-PRF Clot
NCT03331185
Leukocyte-platelet Rich Fibrin for Alveolar Ridge Preservation
NCT05572242
Platelet Rich Fibrin (PRF) in Socket Preservation Technique
NCT06173492
To Compare Ridge Preservation Technique Using Leukocyte Platelet Rich Fibrin (L-PRF) and Freeze-dried Bone Allograft (FDBA) Layered Technique vs L-PRF/FDBA and L-PRF Alone in Influencing Quantity and Quality of New Bone Formation in Grafted Extraction Sockets
NCT04133363
Ridge Preservation After Tooth Extraction Using Cortical Versus Cancellous Freeze Dried Bone Allograft
NCT01588444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Forty subject from the UCSF Dental School who will be having a tooth extracted and replaced with a dental implant will be randomly assigned into the four ridge preservation treatment groups. After three months of healing bone samples from the ridge preservation site will be collected during the implant placement when bone is removed during the osteotomy preparation for the implant. Samples will be evaluated for the extent and quality of bone healing via histomorphometric and micro-CT analysis. Clinical measures of alveolar ridge dimensions will be taken before and after tooth extraction to determine extent of dimensional stability under the different treatment groups.
The four treatments modalities for ridge preservation include autologous platelet rich fibrin (PRF), PRF+freeze dried bone allograft (FDBA), FDBA, collagen barrier membrane. Subjects will be enrolled in the study from the time the socket treated to the time of implant placement (3 months). The results of this study will help to elucidate the extent and quality of bone healing using four different methods for ridge preservation in preparation for implant placement. Further, this study will advance our knowledge of PRF, an autologous sourced blood product used in dentoalveolar surgeries with proven in-vitro qualities but still requiring more extensive clinical testing to demonstrate its full clinical utility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRF
PRF
Autologous blood product used to graft extraction socket
PRF+FDBA
FDBA
Graft material used to graft extraction socket
PRF
Autologous blood product used to graft extraction socket
FDBA
FDBA
Graft material used to graft extraction socket
Blood Clot
Blood Clot
Surgical treatment of extraction socket without addition of graft material
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FDBA
Graft material used to graft extraction socket
PRF
Autologous blood product used to graft extraction socket
Blood Clot
Surgical treatment of extraction socket without addition of graft material
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Intact buccal and lingual plate within approximately 3-4 mm from gingival crest
3. No clinical or radiographic signs of periapical pathology
4. Acceptable oral hygiene
Exclusion Criteria
2. Poor oral hygiene
3. Failing/failed endodontic treatment with history/presence of sinus tracts
4. Pregnant woman or patients who intend to become pregnant
5. Tobacco use
6. Immunosuppressed
7. Type I or type II diabetes
8. Patient with any blood disorder
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Ryder
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Ryder, DDS
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-13360
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.